siRNA therapy reduces triglycerides in individuals along with unusual disorder
.INVESTIGATION FEATURE.19 September 2024.
Plozasiran reduced triglyceride levels through 80% and decreased the danger of pancreatitis in patients along with persistent chylomicronemia, with or without a genetic diagnosis.